Practice of Immunosuppression in Liver Transplant Programs in India: Results of a Survey.
作者信息
Jadaun Shekhar S, Agarwal Shaleen, Gupta Subhash, Saigal Sanjiv
机构信息
Department of Gastroenterology and Hepatology, Centre for Liver and Biliary Sciences, Max Super Speciality Hospital, Saket, New Delhi, India.
Department of Liver Transplant and Gastro Intestinal Surgery, Centre for Liver and Biliary Sciences, Max Super Speciality Hospital, Saket, New Delhi, India.
出版信息
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):377-379. doi: 10.1016/j.jceh.2022.11.004. Epub 2022 Nov 11.
Abstract
摘要
相似文献
1
Practice of Immunosuppression in Liver Transplant Programs in India: Results of a Survey.印度肝移植项目中的免疫抑制实践：一项调查结果
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):377-379. doi: 10.1016/j.jceh.2022.11.004. Epub 2022 Nov 11.
2
Impact of Induction Immunosuppression Strategies in Simultaneous Liver/Kidney Transplantation.肝/肾联合移植中诱导免疫抑制策略的影响。
Transplantation. 2020 Feb;104(2):395-403. doi: 10.1097/TP.0000000000002768.
3
[Review of clinical trials on minimization and interruption of calcineurin inhibitors (CNIs) and protocols without CNIs in the transplantation of different organs (kidney, heart, and liver)].[不同器官（肾脏、心脏和肝脏）移植中钙调神经磷酸酶抑制剂（CNIs）的最小化和中断以及无CNIs方案的临床试验综述]
Nephrol Ther. 2009 Dec;5 Suppl 6:S371-8. doi: 10.1016/S1769-7255(09)73428-5.
4
Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.儿童实体器官移植受者中钙调神经磷酸酶抑制剂诱导的肾毒性的治疗策略。
Pediatr Transplant. 2006 Sep;10(6):721-9. doi: 10.1111/j.1399-3046.2006.00577.x.
5
Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction.对于移植前存在肾功能不全的受者，基于倾向评分法评估同期肝肾联合移植相较于单纯肝移植的生存获益。
Liver Transpl. 2016 Jan;22(1):71-9. doi: 10.1002/lt.24189.
6
Factors associated with cardiovascular events after simultaneous liver-kidney transplant from the US Multicenter Simultaneous Liver-Kidney Transplant Consortium.美国多中心肝肾联合移植协会报告的肝肾联合移植后心血管事件的相关因素。
Hepatol Commun. 2022 Oct 26;7(1):e2108. doi: 10.1002/hep4.2108. eCollection 2023 Jan 1.
7
Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List.肝肾联合移植：对肝移植患者及肾移植等待名单的影响。
Curr Transplant Rep. 2018;5(1):1-6. doi: 10.1007/s40472-018-0175-z. Epub 2018 Jan 19.
8
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway.肾移植后高血压的病理生理学：聚焦钙调神经磷酸酶抑制剂诱导的氧化应激和肾钠潴留以及与RhoA/Rho激酶途径的关系
Kidney Blood Press Res. 2017;42(4):676-685. doi: 10.1159/000483023. Epub 2017 Oct 16.
9
Early use of renal-sparing agents in liver transplantation: a closer look.肝移植中早期使用保肾药物：深入观察。
Liver Transpl. 2013 Aug;19(8):826-42. doi: 10.1002/lt.23672.
10
Differential Simultaneous Liver and Kidney Transplant Benefit Based on Severity of Liver Damage at the Time of Transplantation.基于移植时肝损伤严重程度的肝肾联合移植差异获益情况
Gastroenterology Res. 2017 Apr;10(2):106-115. doi: 10.14740/gr803w. Epub 2017 Apr 19.
引用本文的文献
1
Rejection in Liver Transplantation Recipients.肝移植受者的排斥反应
J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101363. doi: 10.1016/j.jceh.2024.101363. Epub 2024 Feb 22.
本文引用的文献
1
Management of immunosuppressant agents following liver transplantation: Less is more.肝移植后免疫抑制剂的管理：越少越好。
World J Hepatol. 2016 Jan 28;8(3):148-61. doi: 10.4254/wjh.v8.i3.148.
2
Current status of immunosuppression in liver transplantation.肝移植中免疫抑制的现状
J Clin Exp Hepatol. 2013 Jun;3(2):150-8. doi: 10.1016/j.jceh.2013.04.005. Epub 2013 Jun 3.
3
Immunosuppression in liver transplantation.肝移植中的免疫抑制
Liver Transpl. 2005 Nov;11(11):1307-14. doi: 10.1002/lt.20614.
Zotero 插件